Last weekend, I was in the great gay nation of San Francisco for a convention of homosexual journalists. Not that I am one of those mind you. That would be gross. Anyway, after the first day of conventioneering, a few friends and I went out for dinner. It was me, my two boyfriends and three other menfolk whom I did not know eating reasonably priced tapas in the financial district. What fun!
Anyway, no sooner had I begun congratulating myself on scoring a date with five attractive gay men when nearly all of them whipped out their computer phones and began tapping away at the screens. Now, I know I’m no picture to look at, but I’m a reasonably skilled conversationalist, especially with gay boys. Just throw out an “I love your (fill in the blank)” or “You look like you’ve lost weight” and you’ve earned a friend for life.
I just got off the phone with documentarian and Dartmouth College “Visionary-in-Residence” Liz Canner, with whom I was speaking about her provocative new flick called “Orgasm, Inc: The Strange Science of Female Pleasure.” If I can get my mind out of the gutter long enough, I intend to write about her film for Seven Days.
This is a picture of my favorite new drug.
Now generally, I’d have to snark a bit about yet another media offering called “Such and Such, Inc.,” but in Canner’s case, the title is appropriate. Her movie is essentially a multi-year study on big pharma’s attempts to create a female sexual problem so that they can invent and market a drug to fix it. Basically, drug companies are trying to medicalize orgasm issues to make heaps of cash off of women who, uh, can’t get it up?Interesting, because I’m pretty sure if I can’t haul my ass to O-town, it’s not because my lady bits aren’t working right. It’s more like I’m thinking about the dirty dishes in the sink, or the piece I have to finish writing, or the fact that there are cobwebs strung from the ceiling like streamers. Being distracted is different than having a syndrome, a condition or a disease. But enough about me.